FDA.reportPublic FDA data

Application 091496

Type
ANDA
Sponsor
PERRIGO ISRAEL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NITROGLYCERINNITROGLYCERINSPRAY, METERED;SUBLINGUAL0.4MG/SPRAYNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
45802-210nitroglycerin lingualNitroglycerinPadagis Israel Pharmaceuticals LtdANDACurrent
45802-210nitroglycerin lingualNitroglycerinPerrigo New York IncANDACurrent
45802-210nitroglycerin lingualNitroglycerinPerrigo New York IncANDACurrent
45802-210nitroglycerin lingualNitroglycerinPerrigo New York IncANDACurrent
51662-1393NITROGLYCERIN LINGUALNITROGLYCERIN LINGUALHF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1393NITROGLYCERIN LINGUALNITROGLYCERIN LINGUALHF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1423NITROGLYCERIN LINGUALNITROGLYCERIN LINGUALHF Acquisition Co LLC, DBA HealthFirstANDACurrent
51662-1423NITROGLYCERIN LINGUALNITROGLYCERIN LINGUALHF Acquisition Co LLC, DBA HealthFirstANDACurrent
68071-4909nitroglycerin lingualNitroglycerinNuCare Pharmaceuticals,Inc.ANDACurrent
68071-4909nitroglycerin lingualNitroglycerinNuCare Pharmaceuticals,Inc.ANDACurrent
70518-1039nitroglycerin lingualNitroglycerinREMEDYREPACK INC.ANDACurrent
70518-1039nitroglycerin lingualNitroglycerinREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
31535ORIG2013-09-24